Stocks
Funds
Screener
Sectors
Watchlists

Latest Vida Ventures Advisors, LLC Stock Portfolio

Vida Ventures Advisors, LLC Performance:
2024 Q3: 30.41%YTD: 91.19%2023: 22.25%

Performance for 2024 Q3 is 30.41%, and YTD is 91.19%, and 2023 is 22.25%.

About Vida Ventures Advisors, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Vida Ventures Advisors, LLC reported an equity portfolio of $138.6 Millions as of 30 Sep, 2024.

The top stock holdings of Vida Ventures Advisors, LLC are CNTA, , . The fund has invested 45.4% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 22.5% of portfolio in TECTONIC THERAPEUTICS, INC.

Vida Ventures Advisors, LLC opened new stock positions in TECTONIC THERAPEUTICS, INC..

Vida Ventures Advisors, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Vida Ventures Advisors, LLC made a return of 30.41% in the last quarter. In trailing 12 months, it's portfolio return was 136.04%.

New Buys

Ticker$ Bought
tectonic therapeutics, inc.31,168,800

New stocks bought by Vida Ventures Advisors, LLC

Additions

No additions were made to existing positions by Vida Ventures Advisors, LLC

Reductions

None of the existing positions were reduced by Vida Ventures Advisors, LLC

Sold off

None of the stocks were completely sold off by Vida Ventures Advisors, LLC

Sector Distribution

Vida Ventures Advisors, LLC has about 61.6% of it's holdings in Healthcare sector.

Sector%
Healthcare61.6
Others38.4

Market Cap. Distribution

Vida Ventures Advisors, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP49
UNALLOCATED38.4
MID-CAP10.6
MICRO-CAP2

Stocks belong to which Index?

About 14.2% of the stocks held by Vida Ventures Advisors, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others85.8
RUSSELL 200014.2
Top 5 Winners (%)%
CNTA
centessa pharmaceuticals plc
77.1 %
ALLO
allogene therapeutics, inc.
20.2 %
DYN
dyne therapeutics, inc.
1.8 %
Top 5 Winners ($)$
CNTA
centessa pharmaceuticals plc
27.4 M
ALLO
allogene therapeutics, inc.
0.8 M
DYN
dyne therapeutics, inc.
0.3 M
Top 5 Losers (%)%
KRON
kronos bio, inc.
-19.4 %
Top 5 Losers ($)$
KRON
kronos bio, inc.
-0.7 M

Vida Ventures Advisors, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vida Ventures Advisors, LLC

Vida Ventures Advisors, LLC has 6 stocks in it's portfolio. KRON proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for Vida Ventures Advisors, LLC last quarter.

Last Reported on: 08 Oct, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions